comparemela.com

Latest Breaking News On - European medicines agency priority - Page 1 : comparemela.com

Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024

Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

The European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previously received at least 2 treatment regimens.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.